Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers

In endemic foci, the use of an aquaphilic cream containing paromomycin with/without gentamicin to treat cutaneous leishmaniasis (CL) is safe, painless and cures 78-82% of patients with New and Old World CL. Self-application in travelers requires evaluation. Travelers with 1-10 lesions of confirmed C...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PLoS neglected tropical diseases 2023-08, Vol.17 (8), p.e0011492-e0011492
Hauptverfasser:	Mouri, Oussama, Melenotte, Cléa, Guéry, Romain, Cotteret, Camille, Schweitzer-Chaput, Arnaud, Perignon, Alice, Thellier, Marc, Bourrat, Emmanuelle, Kaguelidou, Florentia, Siriez, Jean Yves, Malvy, Denis, Gangneux, Jean-Pierre, Duvignaud, Alexandre, Ravel, Christophe, Cisternino, Salvatore, Ransom, Janet, Caumes, Eric, Lortholary, Olivier, Grogl, Max, Buffet, Pierre
Format:	Artikel
Sprache:	eng
Schlagworte:	Aminoglycoside antibiotics Aminoglycosides Biology and Life Sciences Blood tests Care and treatment Clinical trials Complications and side effects Cutaneous leishmaniasis Dermatology Diagnosis FDA approval Gentamicin Health aspects Human health and pathology Infectious diseases Informed consent Leishmaniasis, Cutaneous Lesions Life Sciences Medicine and Health Sciences Parasites Parasitic diseases Paromomycin Patient outcomes Patients Pentamidine isethionate People and places Pharmaceutical sciences Pharmacology Polymerase chain reaction Protocols Protozoa Pruritus Research and Analysis Methods Santé publique et épidémiologie Surveillance Toxicity Travelers Tropical diseases Ulcers Vector-borne diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!